Gateway 2012: Metrics, Inc. - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2012: Metrics, Inc.

Metrics, Inc.
1240 Sugg Parkway, Greenville, NC 27834

Contact Information:
Jeff Basham, VP Sales & Marketing or 252-752-3800

Metrics Inc. is one of the most respected CDMOs in the US today. Our full range of services includes formulations development, commercial manufacturing, analytical methods development, First Time In Man, potent and cytotoxic drug handling, raw materials testing, trace metals testing and stability storage and testing.

Three critical differences set Metrics apart. One, clients work directly with a senior Metrics pharmaceutical scientist or analytical development chemist. Two, projects are expedited quickly and efficiently; they don’t languish in an analytical development queue, so timelines are met consistently. Three, Metrics’ quality assurance team is highly experienced, ensuring compliance with all regulatory issues.

Metrics is pleased to invite you to visit our booth #1119 at Interphex. To meet our team please contact Jeff Basham, VP of Sales and Marketing, at or 252-752-3800.

Metrics Capabilities Brochure

Metrics Analytical Services

Metrics Potent Products


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here